Efficacy of a Scarf to Facilitate Mother-newborn Contact Designed to Facilitate Skin-to-skin Contact (MOKA)
Randomized Clinical Trial to Evaluate the Efficacy of a Scarf Designed to Facilitate Skin-to-skin Contact Between Parents and Healthy Term Neonates
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Marta Bernadó
- Phone Number: 34-607214125
- Email: recerca@csapg.cat
Study Contact Backup
- Name: Alejandro Rodríguez-Molinero
- Email: arodriguez@csapg.cat
Study Locations
-
-
Barcelona
-
Sant Pere de Ribes, Barcelona, Spain, 08810
- Consorci Sanitari Alt Penedes i Garraf
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Moders attending the first hospital visit with the midwife, with delivery planned in either of the two study hospitals
Exclusion Criteria:
- Language barrier that prevents collaboration in the study procedures
- Cognitive impairment preventing collaboration in the study procedures
- Morbid obesity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Scarf
Two hours after delivery, mothers will be informed of the benefits of the skin-to-skin method, and the towel with which mother and newborn are covered from the moment of delivery will be replaced by a NeoBulleⓇ scarf.
This scarf, which can be used by the mother and/or her partner, is specific for practicing the "skin-to-skin" technique.
It facilitates breastfeeding posture, keeps the newborn well covered and supported on the back.
The NeoBulleⓇ scarf is not a baby carrier device that allows standing or walking without holding the baby with the arms.
Nursing staff will ensure the proper understanding of scarf usage instructions by parents and provide them with written instructions.
Mother and newborn will remain with the NeoBulleⓇ scarf placed in the delivery area until they are transferred to the hospitalization unit.
Once in the hospitalization unit, mothers will have the option to continue contact with the baby using the scarf or dress the newborn.
|
Scarf specifically designed to facilitate mother-neonate skin-to-skin contact
|
|
Active Comparator: Usual clinical practice
Two hours after delivery, mothers will be informed about the benefits of the skin-to-skin method, and the traditional practice in the study centers will be followed, whereby the newborn remains in contact with the mother, covered by a towel, from the moment of birth until both are transferred to the hospitalization unit.
In the hospitalization unit, they will have the option to continue in this manner or dress the newborn.
|
Participants will receive the usual clinical practice
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mother-neonate skin-to-skin contact time (number of hours)
Time Frame: 72 hours
|
Number of hours of skin-to-skin contact maneuver (kangaroo)
|
72 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Newborn weight loss
Time Frame: 72 hours
|
Weight change in grams
|
72 hours
|
|
Parents satisfaction with hospital care
Time Frame: 72 hours
|
Parents satisfaction (structured interview)
|
72 hours
|
|
Time in arms or in physical contact of the neonate with the mother / father
Time Frame: 72 hours
|
Number of hours in arms or in physical contact of the neonate with the mother / father
|
72 hours
|
|
Time of crying
Time Frame: 72 hours
|
Number of hours crying
|
72 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Marta Bernadó, Consorci Sanitari Alt Penedes i Garraf
- Study Director: Alejandro Rodríguez-Molinero, Consorci Sanitari Alt Penedes i Garraf
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- CSAPG-14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.